Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development
BeOne Medicines AG (NASDAQ:ONC) is one of the best healthcare stocks to buy for 2026. On January 13, at the 44th Annual J.P.
Beone Medicines Ltd. (ONC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 40,432 | $12,283,645 | +34% | 3.92% |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $302.06 | 165,529 | $49,999,938.03 | 18,943,802 | 2021-09-10 | Filing | |
| $108.00 | 5,231,900 | $565,045,200.00 | 5,250,491 | 2018-08-02 | Filing | |
| $108.00 | 582,200 | $62,877,600.00 | 600,791 | 2018-08-02 | Filing | |
| $101.00 | 1,645,148 | $166,159,948.00 | 5,121,404 | 2018-01-18 | Filing | |
| $101.00 | 335,050 | $33,840,050.00 | 708,025 | 2018-01-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $350.00 | 996 | $348,600.00 | 0 | 2026-02-04 | Filing | |
| $348.79 | 664 | $231,596.56 | 996 | 2026-02-04 | Filing | |
| $331.76 | 664 | $220,288.64 | 0 | 2026-01-07 | Filing | |
| $305.24 | 40 | $12,209.60 | 0 | 2025-12-16 | Filing | |
| $304.36 | 1,973 | $600,507.41 | 40 | 2025-12-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 152,087 | $46,205,551 | 0.01% | |
| 2. | 76,438 | $23,222,630 | 0.01% | |
| 3. | 42,207 | $12,822,908 | 0.04% | |
| 4. | 30,089 | $9,141,339 | 0.11% | |
| 5. | 27,301 | $8,294,317 | 0.99% |
News See All
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Citizens Highlights BeOne Medicines’ (ONC) $3.8B Revenue Potential for 2025
BeOne Medicines Ltd. (NASDAQ:ONC) ranks among the best high growth European stocks to buy. On January 7, Citizens reaffirmed its Market Outperform rating and $396 price target for BeOne Medicines Ltd.
10 High Growth European Stocks To Buy
European equities began the last week of January in a sour mood, with investors concerned on January 26 about rising geopolitical tensions in anticipation of a Federal Reserve policy meeting and a flood...
Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua International and Global...
BeOne Medicines Ltd. (NASDAQ:ONC) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone. Welcome to BeOne Medicine's Q3 2025 Earnings Call Webcast. [Operator Instructions] After the speakers' remarks, there will be a question-and-answer session.
BeOne Medicines (ONC) Gains Barclays Overweight Rating Ahead of Key 2025 Data Readouts
BeOne Medicines Ltd. (NASDAQ:ONC) ranks among the best biotech stocks to buy. On September 18, Barclays began coverage of BeOne Medicines Ltd.
14 Best Biotech Stocks to Buy Right Now
The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.
Here’s Why BeOne Medicines Ltd. (ONC) Declined in Q2
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its second quarter 2025 investor letter for the "Baird Chautauqua International and Global...
Citizens JMP Maintains a Buy Rating on BeOne Medicines (ONC)
BeOne Medicines Ltd. (NASDAQ:ONC) is one of the top high growth international stocks to buy right now.
Hedge Fund Resource Center Billionaire Hedge Funds
